Phase II And III Zanamivir Treatment Studies

SH 1997 228 227* 455

A 1997?98 365 412* 777

E 1997?98 182 174* 356

A 1995?96 81 68* 71† 220

E 1995?96 63 64* 70† 197

SH 1995?96 183 188* 183† 554

Total 10 mg IH 1102 1133 2235

A & E 1996?97 422 419† 415‡ 1256

*Zanamivir 10 mg IH twice daily for 5 days

†Zanamivir 10 mg IH + 6.4 mg IN twice daily for 5 days

‡Zanamivir 10 mg IH + 6.4 mg IN four times daily for 5 days

Location Year Placebo Zanamivir Total

Previous slide

Next slide

Back to first slide

View graphic version